Skip to main content
Erschienen in: Diabetologia 9/2006

01.09.2006 | Article

Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA

verfasst von: J. A. Bell, E. Volpi, S. Fujita, J. G. Cadenas, B. B. Rasmussen

Erschienen in: Diabetologia | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

An elevated lipid content within skeletal muscle cells is associated with the development of insulin resistance and type 2 diabetes mellitus. We hypothesised that in subjects with type 2 diabetes muscle malonyl-CoA (an inhibitor of fatty acid oxidation) would be elevated at baseline in comparison with control subjects and in particular during physiological hyperinsulinaemia with hyperglycaemia. Thus, fatty acids taken up by muscle would be shunted away from oxidation and towards storage (non-oxidative disposal).

Materials and methods

Six control subjects and six subjects with type 2 diabetes were studied after an overnight fast and during a hyperinsulinaemic (0.5 mU kg−1 min−1), hyperglycaemic clamp (with concurrent intralipid and heparin infusions) designed to increase muscle malonyl-CoA and inhibit fat oxidation. We used stable isotope methods, femoral arterial and venous catheterisation, and performed muscle biopsies to measure palmitate kinetics across the leg and muscle malonyl-CoA.

Results

Basal muscle malonyl-CoA concentrations were similar in control and type 2 diabetic subjects and increased (p<0.05) in both groups during the clamp (control, 0.14±0.05 to 0.24±0.05 pmol/mg; type 2 diabetes, 0.09±0.01 to 0.20±0.02 pmol/mg). Basal palmitate oxidation across the leg was not different between groups at baseline and decreased in both groups during the clamp (p<0.05). Palmitate uptake and non-oxidative disposal were significantly greater in the type 2 diabetic subjects at baseline and during the clamp (p<0.05).

Conclusions/interpretation

Contrary to our hypothesis, the dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of muscle malonyl-CoA. However, elevated fatty acid uptake in type 2 diabetes may be a key contributing factor to the increase in fatty acids being shunted towards storage within muscle.
Literatur
1.
Zurück zum Zitat DeFronzo RA (1997) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Netherlands J Med 50:191–197CrossRef DeFronzo RA (1997) Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Netherlands J Med 50:191–197CrossRef
2.
Zurück zum Zitat Shah P, Vella A, Basu A et al (2003) Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 52:38–42PubMedCrossRef Shah P, Vella A, Basu A et al (2003) Elevated free fatty acids impair glucose metabolism in women: decreased stimulation of muscle glucose uptake and suppression of splanchnic glucose production during combined hyperinsulinemia and hyperglycemia. Diabetes 52:38–42PubMedCrossRef
3.
Zurück zum Zitat Boden G, Lebed B, Schatz M, Homko C, Lemieux S (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612–1617PubMedCrossRef Boden G, Lebed B, Schatz M, Homko C, Lemieux S (2001) Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50:1612–1617PubMedCrossRef
4.
Zurück zum Zitat Itan SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005–2011CrossRef Itan SI, Ruderman NB, Schmieder F, Boden G (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51:2005–2011CrossRef
5.
Zurück zum Zitat Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity [see comment]. J Clin Invest 113:1582–1588PubMed Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity [see comment]. J Clin Invest 113:1582–1588PubMed
6.
Zurück zum Zitat Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000–E1006PubMed Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000–E1006PubMed
7.
Zurück zum Zitat Goodpaster BH, Theriault R, Watkins SC, Kelley DE (2000) Intramuscular lipid content is increased in obesity and decreased by weight loss. Metab Clin Exp 49:467–472PubMed Goodpaster BH, Theriault R, Watkins SC, Kelley DE (2000) Intramuscular lipid content is increased in obesity and decreased by weight loss. Metab Clin Exp 49:467–472PubMed
8.
Zurück zum Zitat Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130–E1141PubMed Kelley DE, Goodpaster B, Wing RR, Simoneau JA (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 277:E1130–E1141PubMed
9.
Zurück zum Zitat Mandarino LJ, Consoli A, Jain A, Kelley DE (1996) Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 270:E463–E470PubMed Mandarino LJ, Consoli A, Jain A, Kelley DE (1996) Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol 270:E463–E470PubMed
10.
Zurück zum Zitat Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933–941PubMedCrossRef Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933–941PubMedCrossRef
11.
Zurück zum Zitat Pan DA, Lillioja S, Kriketos AD et al (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983–988PubMedCrossRef Pan DA, Lillioja S, Kriketos AD et al (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983–988PubMedCrossRef
12.
Zurück zum Zitat Schmitz-Peiffer C, Browne CL, Oakes ND et al (1997) Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46:169–178PubMedCrossRef Schmitz-Peiffer C, Browne CL, Oakes ND et al (1997) Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46:169–178PubMedCrossRef
13.
Zurück zum Zitat Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW (2002) Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci 967:196–207PubMedCrossRef Cooney GJ, Thompson AL, Furler SM, Ye J, Kraegen EW (2002) Muscle long-chain acyl CoA esters and insulin resistance. Ann N Y Acad Sci 967:196–207PubMedCrossRef
14.
Zurück zum Zitat Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579–1585PubMedCrossRef Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE (1997) Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46:1579–1585PubMedCrossRef
15.
Zurück zum Zitat Krssak M, Falk Petersen K, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116 [erratum: Diabetologia 42:386]PubMedCrossRef Krssak M, Falk Petersen K, Dresner A et al (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113–116 [erratum: Diabetologia 42:386]PubMedCrossRef
16.
Zurück zum Zitat Ellis BA, Poynten A, Lowy AJ et al (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279:E554–E560PubMed Ellis BA, Poynten A, Lowy AJ et al (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279:E554–E560PubMed
17.
Zurück zum Zitat Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384–387PubMedCrossRef Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384–387PubMedCrossRef
18.
Zurück zum Zitat McGarry JD (1995) Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans 23:481–485PubMed McGarry JD (1995) Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem Soc Trans 23:481–485PubMed
19.
Zurück zum Zitat Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, Wolfe RR (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle [see comment]. J Clin Invest 110:1687–1693PubMed Rasmussen BB, Holmback UC, Volpi E, Morio-Liondore B, Paddon-Jones D, Wolfe RR (2002) Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle [see comment]. J Clin Invest 110:1687–1693PubMed
20.
Zurück zum Zitat Ravikumar B, Carey PE, Snaar JE (2005) Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288:E789–E797PubMedCrossRef Ravikumar B, Carey PE, Snaar JE (2005) Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am J Physiol Endocrinol Metab 288:E789–E797PubMedCrossRef
21.
Zurück zum Zitat Bonen A, Parolin ML, Steinberg GR et al (2004) Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18:1144–1146PubMed Bonen A, Parolin ML, Steinberg GR et al (2004) Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J 18:1144–1146PubMed
22.
Zurück zum Zitat Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef
23.
Zurück zum Zitat Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118–2124PubMed Patterson BW, Zhao G, Elias N, Hachey DL, Klein S (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118–2124PubMed
24.
Zurück zum Zitat Wolfe RR (1992) Radioactive and stable isotope tracers in biomedicine. Wiley-Liss, New York Wolfe RR (1992) Radioactive and stable isotope tracers in biomedicine. Wiley-Liss, New York
25.
Zurück zum Zitat Sacchetti M, Saltin B, Osada T, van Hall G (2002) Intramuscular fatty acid metabolism in contracting and non-contracting human skeletal muscle. J Physiol 540:387–395PubMedCrossRef Sacchetti M, Saltin B, Osada T, van Hall G (2002) Intramuscular fatty acid metabolism in contracting and non-contracting human skeletal muscle. J Physiol 540:387–395PubMedCrossRef
26.
Zurück zum Zitat Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Resp Environ Exerc Physiol 55:628–634 Frayn KN (1983) Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Resp Environ Exerc Physiol 55:628–634
27.
Zurück zum Zitat Sacchetti M, Saltin B, Olsen D, van Hall G (2004) High triacylglycerol turnover rate in human skeletal muscle. J Physiol 561.3:883–891CrossRef Sacchetti M, Saltin B, Olsen D, van Hall G (2004) High triacylglycerol turnover rate in human skeletal muscle. J Physiol 561.3:883–891CrossRef
28.
Zurück zum Zitat van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues: the effect of exercise. J Physiol 543:1033–1046PubMedCrossRef van Hall G, Bulow J, Sacchetti M, Al Mulla N, Lyngso D, Simonsen L (2002) Regional fat metabolism in human splanchnic and adipose tissues: the effect of exercise. J Physiol 543:1033–1046PubMedCrossRef
29.
Zurück zum Zitat Saha AK, Vavvas D, Kurowski TG et al (1997) Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol 272:E641–E648PubMed Saha AK, Vavvas D, Kurowski TG et al (1997) Malonyl-CoA regulation in skeletal muscle: its link to cell citrate and the glucose-fatty acid cycle. Am J Physiol 272:E641–E648PubMed
30.
Zurück zum Zitat Winder WW, Arogyasami J, Elayan IM, Cartmill D (1990) Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol 259:E266–E271PubMed Winder WW, Arogyasami J, Elayan IM, Cartmill D (1990) Time course of exercise-induced decline in malonyl-CoA in different muscle types. Am J Physiol 259:E266–E271PubMed
31.
Zurück zum Zitat Mills SE, Foster DW, McGarry JD (1983) Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Biochem J 214:83–91PubMed Mills SE, Foster DW, McGarry JD (1983) Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I. Biochem J 214:83–91PubMed
32.
Zurück zum Zitat Jorfeldt L, Juhlin-Dannfelt A (1978) The influence of ethanol on splanchnic and skeletal muscle metabolism in man. Metab Clin Exp 27:97–106PubMed Jorfeldt L, Juhlin-Dannfelt A (1978) The influence of ethanol on splanchnic and skeletal muscle metabolism in man. Metab Clin Exp 27:97–106PubMed
33.
Zurück zum Zitat Jorfeldt L, Wahren J (1971) Leg blood flow during exercise in man. Clin Sci 41:459–473PubMed Jorfeldt L, Wahren J (1971) Leg blood flow during exercise in man. Clin Sci 41:459–473PubMed
34.
Zurück zum Zitat Bavenholm PN, Pigon J, Saha AK, Ruderman NB, Efendic S (2000) Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes 49:1078–1083PubMedCrossRef Bavenholm PN, Pigon J, Saha AK, Ruderman NB, Efendic S (2000) Fatty acid oxidation and the regulation of malonyl-CoA in human muscle. Diabetes 49:1078–1083PubMedCrossRef
35.
Zurück zum Zitat Bavenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S (2003) Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. J Clin Endocrinol Metab 88:82–87 [erratum: J Clin Endocrinol Metab 88:2036]PubMedCrossRef Bavenholm PN, Kuhl J, Pigon J, Saha AK, Ruderman NB, Efendic S (2003) Insulin resistance in type 2 diabetes: association with truncal obesity, impaired fitness, and atypical malonyl coenzyme A regulation. J Clin Endocrinol Metab 88:82–87 [erratum: J Clin Endocrinol Metab 88:2036]PubMedCrossRef
36.
Zurück zum Zitat Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of capacity to utilise fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051–2060PubMed Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of capacity to utilise fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051–2060PubMed
37.
Zurück zum Zitat Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed Simoneau JA, Kelley DE (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J Appl Physiol 83:166–171PubMed
38.
Zurück zum Zitat Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950PubMedCrossRef Kelley DE, He J, Menshikova EV, Ritov VB (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51:2944–2950PubMedCrossRef
39.
Zurück zum Zitat Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356PubMedCrossRef Kelley DE, Simoneau JA (1994) Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest 94:2349–2356PubMedCrossRef
40.
Zurück zum Zitat Hulver MW, Berggren JR, Cortright RN et al (2003) Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741–E747PubMed Hulver MW, Berggren JR, Cortright RN et al (2003) Skeletal muscle lipid metabolism with obesity. Am J Physiol Endocrinol Metab 284:E741–E747PubMed
41.
Zurück zum Zitat Golay A, Felber JP, Meyer HU, Curchod B, Maeder E, Jequier E (1984) Study on lipid metabolism in obesity diabetes. Metab Clin Exp 33:111–116PubMed Golay A, Felber JP, Meyer HU, Curchod B, Maeder E, Jequier E (1984) Study on lipid metabolism in obesity diabetes. Metab Clin Exp 33:111–116PubMed
42.
Zurück zum Zitat Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341–1350PubMedCrossRef Felber JP, Ferrannini E, Golay A et al (1987) Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341–1350PubMedCrossRef
43.
Zurück zum Zitat Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma NEFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146–E154PubMed Blaak EE, Wagenmakers AJ, Glatz JF et al (2000) Plasma NEFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. Am J Physiol Endocrinol Metab 279:E146–E154PubMed
44.
Zurück zum Zitat Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548–2554PubMedCrossRef Mensink M, Blaak EE, van Baak MA, Wagenmakers AJ, Saris WH (2001) Plasma free fatty acid uptake and oxidation are already diminished in subjects at high risk for developing type 2 diabetes. Diabetes 50:2548–2554PubMedCrossRef
Metadaten
Titel
Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA
verfasst von
J. A. Bell
E. Volpi
S. Fujita
J. G. Cadenas
B. B. Rasmussen
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 9/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0362-9

Weitere Artikel der Ausgabe 9/2006

Diabetologia 9/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.